Arthritis & Rheumatology (Hoboken, N.J.); Fraenkel L, Bathon JM et. al.
Jun 9th, 2021 - To develop updated guidelines for the pharmacologic management of rheumatoid arthritis. We developed clinically relevant population, intervention, comparator, and outcomes (PICO) questions. After conducting a systematic literature review, the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used to rate the certainty of evidence. A voting panel comprising c...
Arthritis & Rheumatology (Hoboken, N.J.); Ward MM, Deodhar A et. al.
Aug 23rd, 2019 - To update evidence-based recommendations for the treatment of patients with ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). We conducted updated systematic literature reviews for 20 clinical questions on pharmacologic treatment addressed in the 2015 guidelines, and for 26 new questions on pharmacologic treatment, treat-to-target strategy, and use of imaging. New q...
Journal of the American College of Cardiology; Sachdev V, Sharma K et. al.
Mar 24th, 2023 - Heart failure with preserved ejection fraction (HFpEF) is one of the most common forms of heart failure; its prevalence is increasing, and outcomes are worsening. Affected patients often experience severe exertional dyspnea and debilitating fatigue, as well as poor quality of life, frequent hospitalizations, and a high mortality rate. Until recently, most pharmacological intervention trials for...
Chest Sprung CL, Devereaux AV et. al.
Mar 13th, 2023 - The 2019 coronavirus disease (COVID-19) pandemic has led to unprecedented mental health disturbances, burnout, and moral distress among healthcare workers, impacting their ability to care for themselves and their patients. The Workforce Sustainment subcommittee of the Task Force for Mass Critical Care (TFMCC) utilized a consensus development process, incorporating evidence from literature revie...
Neonatology Sweet DG, Carnielli VP et. al.
Mar 3rd, 2023 - Respiratory distress syndrome (RDS) care pathways evolve slowly as new evidence emerges. We report the sixth version of "European Guidelines for the Management of RDS" by a panel of experienced European neonatologists and an expert perinatal obstetrician based on available literature up to end of 2022. Optimising outcome for babies with RDS includes prediction of risk of preterm delivery, appro...
Nature Methods; Gatto L, Aebersold R et. al.
Mar 3rd, 2023 - Analyzing proteins from single cells by tandem mass spectrometry (MS) has recently become technically feasible. While such analysis has the potential to accurately quantify thousands of proteins across thousands of single cells, the accuracy and reproducibility of the results may be undermined by numerous factors affecting experimental design, sample preparation, data acquisition and data analy...
European Urology Focus; Nguyen DD, Wallis CJD et. al.
Feb 27th, 2023 - Cancer survivorship is particularly significant for patients with urologic malignancies, who account for >25% of cancer survivors. The American Cancer Society has a guideline on survivorship care in prostate cancer and the American Urological Association has published a core curriculum on cancer survivorship in urologic cancers. However, there is a lack of high-quality evidence on survivorship ...
Gastroenterology Singh S, Ananthakrishnan AN et. al.
Feb 24th, 2023 - Biomarkers are used frequently for noninvasive monitoring and treatment decision making in the management of patients with ulcerative colitis (UC). This American Gastroenterological Association (AGA) guideline is intended to support practitioners in decisions about the use of biomarkers for the management of UC. A multidisciplinary panel of content experts and guideline methodologists used the ...
Clinical Nutrition (Edinburgh, Scotland); Pironi L, Boeykens K et. al.
Feb 17th, 2023 - This guideline will inform physicians, nurses, dieticians, pharmacists, caregivers and other home parenteral nutrition (HPN) providers, as well as healthcare administrators and policy makers, about appropriate and safe HPN provision. This guideline will also inform patients requiring HPN. The guideline is based on previous published guidelines and provides an update of current evidence and expe...
JAMA , Mangione CM et. al.
Feb 15th, 2023 - Genital herpes is a common sexually transmitted infection caused by 2 related viruses, herpes simplex type 1 (HSV-1) and herpes simplex type 2 (HSV-2). Infection is lifelong; currently, there is no cure for HSV infection. Antiviral medications may provide clinical benefits to symptomatic persons. Transmission of HSV from a pregnant person to their infant can occur, most commonly during delivery...
Early Human Development; Wilkinson AR, Adams GGW et. al.
Feb 14th, 2023 - UK screening and treatment of retinopathy of prematurity Updated 2022 Guidelines.|2023|Wilkinson AR,Adams GGW,Fleck BW,Nieto-Hernandez R, ,|diagnosis,
Clinical Nutrition (Edinburgh, Scotland); Bischoff SC, Bager P et. al.
Feb 6th, 2023 - The present guideline is an update and extension of the ESPEN scientific guideline on Clinical Nutrition in Inflammatory Bowel Disease published first in 2017. The guideline has been rearranged according to the ESPEN practical guideline on Clinical Nutrition in Inflammatory Bowel Disease published in 2020. All recommendations have been checked and, if needed, revised based on new literature, be...
Neuromuscular Disorders : NMD; Benarroch L, Bonne G et. al.
Jan 26th, 2023 - The 2023 version of the gene table of neuromuscular disorders (nuclear genome).|2023|Benarroch L,Bonne G,Rivier F,Hamroun D,|genetics,
Journal of Thrombosis and Haemostasis : JTH; Iba T, Levy JH et. al.
Jan 26th, 2023 - Disseminated intravascular coagulation (DIC) is not a disease criterion but a pathomechanistic process that accompanies various underlying diseases. According to the International Society on Thrombosis and Haemostasis definition, endothelial injury is an essential component in addition to systemic coagulation activation. Despite this definition, current diagnostic criteria for DIC do not includ...
PloS One; Gaugain L, Cawston H et. al.
Jan 19th, 2023 - The IMbrave150 clinical trial assessed the efficacy and safety of atezolizumab in combination with bevacizumab (ATZ+BVA) versus sorafenib in adults with advanced/unresectable hepatocellular carcinoma, who have not received prior systemic treatment. Our aim was to assess the cost-effectiveness of ATZ+BVA versus sorafenib in France based on an updated prices and considering French National real-w...
Chest Abu-Sultaneh S, Iyer NP et. al.
Dec 24th, 2022 - Common, operational definitions are crucial to assess interventions and outcomes related to pediatric mechanical ventilation. These definitions can reduce unnecessary variability among research and quality improvement efforts, to ensure findings are generalizable, and can be pooled to establish best practices. Can we establish operational definitions for key elements related to pediatric ventil...
Annals of Oncology : Official Journal of the European Soc... Krämer A, Bochtler T et. al.
Dec 24th, 2022 - Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.|2022|Krämer A,Bochtler T,Pauli C,Baciarello G,Delorme S,|pathology,
Clinical Gastroenterology and Hepatology : the Official C... Cavestro GM, Mannucci A et. al.
Dec 23rd, 2022 - Patients with early-onset colorectal cancer (eoCRC) are managed according to guidelines that are not age-specific. A multidisciplinary international group (DIRECt), composed of 69 experts, was convened to develop the first evidence-based consensus recommendations for eoCRC. After reviewing the published literature, a Delphi methodology was used to draft and respond to clinically relevant questi...
Ophthalmology Hutchinson AK, Morse CL et. al.
Dec 22nd, 2022 - Pediatric Eye Evaluations Preferred Practice Pattern.|2022|Hutchinson AK,Morse CL,Hercinovic A,Cruz OA,Sprunger DT,|
Annals of Oncology : Official Journal of the European Soc... Bossi P, Chan AT et. al.
Dec 19th, 2022 - ESMO-EURACAN Clinical Practice Guideline update for nasopharyngeal carcinoma: adjuvant therapy and first-line treatment of recurrent/metastatic disease.|2022|Bossi P,Chan AT,Even C,Machiels JP, ,|pathology,therapeutic use,